This website uses cookies. By using this website, you agree to our Cookie Policy.
May 07, 2021
Intellectual Property Group chair and partner Dorothy Auth shares her insights on the Biden administration’s support of a proposed WTO temporary waiver on intellectual property protections for COVID-19 vaccines.